Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 728258, 10 pages
http://dx.doi.org/10.1155/2013/728258
Research Article

A New Herbal Formula, KSG-002, Suppresses Breast Cancer Growth and Metastasis by Targeting NF-κB-Dependent TNFα Production in Macrophages

1Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, Kyung Hee University, 1 Hoegi, Seoul 130-701, Republic of Korea
2Center for Clinical Research and Genomics, Department of Preventive Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea

Received 27 December 2012; Revised 8 March 2013; Accepted 9 May 2013

Academic Editor: David Baxter

Copyright © 2013 Sang-Mi Woo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and L. M. Coussens, “Accessories to the crime: functions of cells recruited to the tumor microenvironment,” Cancer Cell, vol. 21, pp. 309–322, 2012. View at Google Scholar
  2. A. Artacho-Cordon, F. Artacho-Cordon, S. Rios-Arrabal, I. Calvente, and M. I. Nunez, “Tumor microenvironment and breast cancer progression: a complex scenario,” Cancer Biology and Therapy, vol. 13, pp. 14–24, 2012. View at Google Scholar
  3. D. Spano and M. Zollo, “Tumor microenvironment: a main actor in the metastasis process,” Clinical and Experimental Metastasis, vol. 29, pp. 381–395, 2012. View at Google Scholar
  4. A. Mantovani and A. Sica, “Macrophages, innate immunity and cancer: balance, tolerance, and diversity,” Current Opinion in Immunology, vol. 22, no. 2, pp. 231–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Ruffell, N. I. Affara, and L. M. Coussens, “Differential macrophage programming in the tumor microenvironment,” Trends in Immunology, vol. 33, pp. 119–126, 2012. View at Google Scholar
  6. S. B. Coffelt, R. Hughes, and C. E. Lewis, “Tumor-associated macrophages: effectors of angiogenesis and tumor progression,” Biochimica et Biophysica Acta, vol. 1796, no. 1, pp. 11–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Solinas, F. Marchesi, C. Garlanda, A. Mantovani, and P. Allavena, “Inflammation-mediated promotion of invasion and metastasis,” Cancer and Metastasis Reviews, vol. 29, no. 2, pp. 243–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. W. L. W. Hsiao and L. Liu, “The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights,” Planta Medica, vol. 76, no. 11, pp. 1118–1131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. H. J. Burstein, K. Polyak, J. S. Wong, S. C. Lester, and C. M. Kaelin, “Ductal carcinoma in situ of the breast,” The New England Journal of Medicine, vol. 350, no. 14, pp. 1430–1441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Yang, M. Bocchetta, B. Kroczynska et al., “TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10397–10402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zhang, B. Stirling, S. T. Temmerman et al., “Impaired regulation of NF-κB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice,” The Journal of Clinical Investigation, vol. 116, no. 11, pp. 3042–3049, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Mocellin, C. R. Rossi, P. Pilati, and D. Nitti, “Tumor necrosis factor, cancer and anticancer therapy,” Cytokine and Growth Factor Reviews, vol. 16, no. 1, pp. 35–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Jedinak, S. Dudhgaonkar, and D. Sliva, “Activated macrophages induce metastatic behavior of colon cancer cells,” Immunobiology, vol. 215, no. 3, pp. 242–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Oguma, H. Oshima, M. Aoki et al., “Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells,” EMBO Journal, vol. 27, no. 12, pp. 1671–1681, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Inoue, J. Gohda, T. Akiyama, and K. Semba, “NF-κB activation in development and progression of cancer,” Cancer Science, vol. 98, no. 3, pp. 268–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. V. F. Shih, R. Tsui, A. Caldwell, and A. Hoffmann, “A single NFκB system for both canonical and non-canonical signaling,” Cell Research, vol. 21, no. 1, pp. 86–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Rosenblum and H. Amital, “Anti-TNF therapy: safety aspects of taking the risk,” Autoimmunity Reviews, vol. 10, no. 9, pp. 563–568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Zidi, S. Mestiri, A. Bartegi, and N. B. Amor, “TNF-α and its inhibitors in cancer,” Medical Oncology, vol. 27, no. 2, pp. 185–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Wang, S. Penchala, S. Prabhu, J. Wang, and Y. Huang, “Molecular basis of traditional chinese medicine in cancer chemoprevention,” Current Drug Discovery Technologies, vol. 7, no. 1, pp. 67–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. H. Chiu, H. Y. Hsieh, and S. C. Wang, “Prescriptions of traditional Chinese medicine are specific to cancer types and adjustable to temperature changes,” PLoS One, vol. 7, Article ID e31648, 2012. View at Google Scholar
  22. Y. H. Lin and J. H. Chiu, “Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan,” Complementary Therapies in Medicine, vol. 19, no. 3, pp. 137–143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Shin, J. Y. Son, J. K. Kang, S. H. Han, C. K. Cho, and C. G. Son, “Trichosanthes kirilowii tuber extract induces G2/M phase arrest via inhibition of tubulin polymerization in HepG2 cells,” Journal of Ethnopharmacology, vol. 115, no. 2, pp. 209–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kongtun, W. Jiratchariyakul, T. Kummalue, P. Tan-ariya, S. Kunnachak, and A. W. Frahm, “Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina,” Planta Medica, vol. 75, no. 8, pp. 839–842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. B. G. Heo, S. U. Chon, Y. J. Park et al., “Antiproliferative activity of Korean wild vegetables on different human tumor cell lines,” Plant Foods for Human Nutrition, vol. 64, no. 4, pp. 257–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. K. Li, W. J. Kuang, Y. F. Huang et al., “Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo,” Indian Journal of Pharmacology, vol. 44, pp. 78–81, 2012. View at Google Scholar
  27. W. C. S. Cho and K. N. Leung, “In vitro and in vivo anti-tumor effects of Astragalus membranaceus,” Cancer Letters, vol. 252, no. 1, pp. 43–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. X. D. Cheng, C. H. Hou, X. J. Zhang et al., “Effects of Huangqi (Hex) on inducing cell differentiation and cell death in K562 and HEL cells,” Acta Biochimica et Biophysica Sinica, vol. 36, no. 3, pp. 211–217, 2004. View at Google Scholar · View at Scopus
  29. R. Cui, J. He, B. Wang et al., “Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats,” Cancer Chemotherapy and Pharmacology, vol. 51, no. 1, pp. 75–80, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. C. Du, K. Z. Yang, and X. F. Sun, “Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage,” Chinese Journal of Integrative Medicine, vol. 15, no. 3, pp. 184–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Laoui, K. Movahedi, E. van Overmeire et al., “Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions,” International Journal of Developmental Biology, vol. 55, no. 7–9, pp. 861–867, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. R. A. Mukhtar, A. P. Moore, O. Nseyo et al., “Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity,” Breast Cancer Research and Treatment, vol. 130, no. 2, pp. 635–644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Medrek, F. Ponten, K. Jirstrom, and K. Leandersson, “The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients,” BMC Cancer, vol. 12, article 306, 2012. View at Google Scholar
  34. W. D. Foulkes, I. E. Smith, and J. S. Reis-Filho, “Triple-negative breast cancer,” The New England Journal of Medicine, vol. 363, no. 20, pp. 1938–1948, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal, “Breast cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, pp. 409–418, 2011. View at Google Scholar
  36. C. Sotiriou and L. Pusztai, “Gene-expression signatures in breast cancer,” The New England Journal of Medicine, vol. 360, no. 8, pp. 752–800, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. P. Kang, M. Martel, and L. N. Harris, “Triple negative breast cancer: current understanding of biology and treatment options,” Current Opinion in Obstetrics and Gynecology, vol. 20, no. 1, pp. 40–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Metro and A. Fabi, “New target therapies for brain metastases from breast cancer,” Current Cancer Drug Targets, vol. 12, pp. 210–217, 2012. View at Google Scholar
  39. H. Yagata, Y. Kajiura, and H. Yamauchi, “Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy,” Breast Cancer, vol. 18, no. 3, pp. 165–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Wu, J. B. Xu, Y. L. He et al., “Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer,” Journal of Surgical Oncology, vol. 106, pp. 462–468, 2012. View at Google Scholar
  41. W. Chen, T. Ma, X. N. Shen et al., “Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway,” Liver Transplantation, vol. 18, pp. S160–S160, 2012. View at Google Scholar